Iconiq Capital, LLC Novartis Ag Transaction History
Iconiq Capital, LLC
- $4.79 Billion
- Q4 2024
A detailed history of Iconiq Capital, LLC transactions in Novartis Ag stock. As of the latest transaction made, Iconiq Capital, LLC holds 6,074 shares of NVS stock, worth $664,191. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,074
Previous 4,054
49.83%
Holding current value
$664,191
Previous $466,000
26.82%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,474Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.34 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.21 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$895 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$751 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$610 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $235B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...